Evaluating Healthcare AI Before Deployment

Healthcare AI development often receives more attention than healthcare AI selection.

That is a problem.

Organizations increasingly purchase predictive models, clinical decision support systems, generative AI tools, and workflow automation platforms from external vendors. Yet the evaluation process can sometimes focus heavily on demonstrations, benchmark metrics, and feature comparisons.

A better approach is to evaluate the system across its entire operational lifecycle.

First, examine the evidence. What population was used for development? Was the model externally validated? Are the reported metrics relevant to the intended clinical task?

Next, examine transportability. Healthcare data varies substantially across institutions because of differences in patient populations, coding practices, workflows, equipment, clinical protocols, and documentation.

Then examine integration. A highly accurate model that cannot reliably access the required data or deliver outputs at the right point in the workflow may produce little practical value.

Monitoring is equally important. After deployment, organizations need mechanisms for detecting performance degradation, unexpected behavior, data changes, and safety issues.

For agentic systems, the evaluation becomes even broader because the system may initiate actions or coordinate workflows. In such settings, organizations must understand not only predictive performance but also action reliability, authorization boundaries, escalation mechanisms, and human oversight.

Healthcare AI procurement should therefore be treated as part of AI governance.

The goal is not simply to identify the most impressive technology.

It is to identify the technology whose evidence, risks, integration requirements, and expected value are appropriate for the environment in which it will operate.